Literature DB >> 3499142

Purification and renaturation of recombinant human interleukin-2.

M P Weir1, J Sparks.   

Abstract

Recombinant human interleukin-2 (IL-2) expressed as Escherichia coli was isolated as insoluble aggregates of protein (inclusion bodies) after cell breakage. IL-2 and contaminants were dissolved in 6 M-guanidinium chloride/10 mM-dithiothreitol, pH 8.5, and further purified in reduced and denatured form by gel-permeation chromatography in the same solvent. Renaturation was effected by dilution and autoxidation; IL-2 of native specific activity was isolated at over 95% purity by reversed-phase h.p.l.c.; an additional peak of reduced protein was also observed. Most losses of native IL-2 occurred on refolding, probably because of an aggregation process; concentrations around 1 microgram/ml were necessary to achieve 30% recovery. It was essential to maintain the denatured protein in reduced form before renaturation and autoxidation, which was most efficient at pH 8.5 with 1.5 microM-CuSO4. A procedure based on these observations has been used to prepare IL-2 on the 50 micrograms scale.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499142      PMCID: PMC1148085          DOI: 10.1042/bj2450085

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum.

Authors:  P Walter; G Blobel
Journal:  Nature       Date:  1982-10-21       Impact factor: 49.962

4.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

5.  Construction and analysis of in vivo activity of E. coli promoter hybrids and promoter mutants that alter the -35 to -10 spacing.

Authors:  D R Russell; G N Bennett
Journal:  Gene       Date:  1982-12       Impact factor: 3.688

6.  The renaturation of reduced chymotrypsinogen A in guanidine HCl. Refolding versus aggregation.

Authors:  G Orsini; M E Goldberg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

7.  Codon catalog usage is a genome strategy modulated for gene expressivity.

Authors:  R Grantham; C Gautier; M Gouy; M Jacobzone; R Mercier
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

8.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

9.  Trans-complementable copy-number mutants of plasmid ColE1.

Authors:  A J Twigg; D Sherratt
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

10.  Synthetic sites for transcription termination and a functional comparison with tryptophan operon termination sites in vitro.

Authors:  G E Christie; P J Farnham; T Platt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more
  7 in total

1.  Improved folding yields of a model protein using protein disulfide isomerase.

Authors:  C Du; J M Ye; J L Wolfe
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

2.  Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.

Authors:  Uzma Fatima; Balvinder Singh; Karthikeyan Subramanian; Purnananda Guptasarma
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

3.  Effects of temperature on Escherichia coli overproducing beta-lactamase or human epidermal growth factor.

Authors:  J J Chalmers; E Kim; J N Telford; E Y Wong; W C Tacon; M L Shuler; D B Wilson
Journal:  Appl Environ Microbiol       Date:  1990-01       Impact factor: 4.792

4.  Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.

Authors:  G J Graham; P C Wilkinson; R J Nibbs; S Lowe; S O Kolset; A Parker; M G Freshney; M L Tsang; I B Pragnell
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

5.  Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.

Authors:  R Solari; D Quint; H Obray; A McNamee; E Bolton; P Hissey; B Champion; E Zanders; A Chaplin; B Coomber
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

6.  The use of sarkosyl in generating soluble protein after bacterial expression.

Authors:  S Frankel; R Sohn; L Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Directed evolution of super-secreted variants from phage-displayed human Interleukin-2.

Authors:  Gertrudis Rojas; Tania Carmenate; Julio Felipe Santo-Tomás; Pedro A Valiente; Marlies Becker; Annia Pérez-Riverón; Yaima Tundidor; Yaquelín Ortiz; Jorge Fernandez de Cossio-Diaz; Luis Graça; Stefan Dübel; Kalet León
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.